MR in mouse models of cardiac disease

NMR in Biomedicine

Volumn 20, Issue 3, 2007, Pages 238-255

  Epstein, Frederick H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cardiac disease; Heart; Mouse models; Myocardial infarction

Indexed keywords

COAGULATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NONINVASIVE MEDICAL PROCEDURES; PATHOLOGY; PHYSIOLOGY;

BLOOD COAGULATION FACTOR; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY;

CARDIOLOGY;

ALLOPURINOL; ANGIOTENSIN 2 RECEPTOR; BLOOD CLOTTING FACTOR 13; CALCIUM; INDUCIBLE NITRIC OXIDE SYNTHASE; MYOGLOBIN; NEURONAL NITRIC OXIDE SYNTHASE; OXIPURINOL; TROPONIN I; XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; ENERGY TRANSFER; ENZYME INHIBITION; GENETIC ENGINEERING; HEART CONTRACTION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE METABOLISM; HEART PERFUSION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVIEW; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; HEART DISEASES; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MYOCARDIAL INFARCTION;

MUS;

EID: 34249751168     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1152     Document Type: Review

References (96)

1. Carmeliet P, Collen D. Transgenic mouse models in angiogenesis and cardiovascular disease. Journal of Pathology 2000; 190: 387-405.
2. Hoit BD. New approaches to phenotypic analysis in adult mice. Journal of Molecular & Cellular Cardiology 2001; 33: 27-35.
3. Franco F, Dubois SK, Peshock RM, Shohet RV. Magnetic resonance imaging accurately estimates LV mass in a transgenic mouse model of cardiac hypertrophy. American Journal of Physiology 1998; 274: H679-H683.
4. Herold V, Morchel P, Faber C, Rommel E, Haase A, Jakob PM. In vivo quantitative three-dimensional motion mapping of the murine myocardium with PC-MRI at 17.6 T. Magnetic Resonance in Medicine 2006; 55: 1058-1064.
5. Janssen BJ, De Celle T, Debets JJ, Brouns AE, Callahan ME, Smith TL. Effects of anesthetics on systemic hemodynamics in mice. American Journal of Physiology - Heart & Circulatory Physiology 2004; 287: H1618-H1624.
6. Zuurbier CJ, Emons VM, Ince C, Zuurbier CJ, Emons VM, Ince C. Hemodynamics of anesthetized ventilated mouse models: aspects of anesthetics, fluid support, and strain. American Journal of Physiology - Heart & Circulatory Physiology 2002; 282: H2099-H2105.
7. Kober F, Iltis I, Cozzone PJ, Bernard M. Cine-MRI assessment of cardiac function in mice anesthetized with ketamine/xylazine and isoflurane. Magma 2004; 17: 157-161.
8. Kober F, Iltis I, Cozzone PJ, Bernard M. Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia. Magnetic Resonance in Medicine 2005; 53: 601-606.
9. Cassidy PJ, Schneider JE, Grieve SM, Lygate C, Neubauer S, Clarke K, Clarke K. Assessment of motion gating strategies for mouse magnetic resonance at high magnetic fields. Journal of Magnetic Resonance Imaging 2004; 19: 229-237.
10. Hiba B, Richard N, Janier M, Croisille P. Cardiac and respiratory double self-gated cine MRI in the mouse at 7 T. Magnetic Resonance in Medicine 2006; 55: 506-513.
11. Brau AC, Wheeler CT, Hedlund LW, Johnson GA. Fiber-optic stethoscope: a cardiac monitoring and gating system for magnetic resonance microscopy. Magnetic Resonance in Medicine 2002; 47: 314-321.
12. Slawson SE, Roman BB, Williams DS, Koretsky AR Cardiac MRI of the normal and hypertrophied mouse heart. Magnetic Resonance in Medicine 1998; 39: 980-987.
13. Berr SS, Roy RJ, French BA, Yang Z, Gilson W, Kramer CM, Epstein FH. Black blood gradient echo cine magnetic resonance imaging of the mouse heart. Magnetic Resonance in Medicine 2005; 53: 1074-1079.
14. Franco F, Thomas GD, Giroir B, Bryant D, Bullock MC, Chwialkowski MC, Victor RG, Peshock RM. Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1999; 99: 448-454.
15. Ruff J, Wiesmann F, Hiller KH, Voll S, von Kienlin M, Bauer WR, Rommel E, Neubauer S, Haase A. Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magnetic Resonance in Medicine 1998; 40: 43-48.
16. Wiesmann F, Frydrychowicz A, Rautenberg J, Illinger R, Rommel E, Haase A, Neubauer S. Analysis of right ventricular function in healthy mice and a murine model of heart failure by in vivo MRI. American Journal of Physiology - Heart & Circulatory Physiology 2002; 283: H1065-H1071.
17. Wiesmann F, Ruff J, Hiller KH, Rommel E, Haase A, Neubauer S. Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. American Journal of Physiology - Heart & Circulatory Physiology 2000; 278: H652-H657.
18. Axel L, Dougherty L. MR imaging of motion with spatial modulation of magnetization. Radiology 1989; 171: 841-845.
19. de Crespigny AJ, Carpenter TA, Hall LD. Cardiac tagging in the rat using a DANTE sequence. Magnetic Resonance in Medicine 1991; 21: 151-156.
20. Henson RE, Song SK, Pastorek JS, Ackerman JJ, Lorenz CH. Left ventricular torsion is equal in mice and humans. American Journal of Physiology - Heart & Circulatory Physiology 2000; 278: H1117-H1123.
21. Zhou R, Pickup S, Glickson JD, Scott CH, Ferrari VA. Assessment of global and regional myocardial function in the mouse using cine and tagged MRI. Magnetic Resonance in Medicine 2003; 49: 760-764.
22. Epstein FH, Yang Z, Gilson WD, Berr SS, Kramer CM, French BA. MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions. Magnetic Resonance in Medicine 2002; 48: 399-403.
23. Young AA, French BA, Yang Z, Cowan BR, Gilson WD, Berr SS, Kramer CM, Epstein FH. Reperfused myocardial infarction in mice: 3D mapping of late gadolinium enhancement and strain. Journal of Cardiovascular Magnetic Resonance Imaging 2006; 8: 685-692.
24. Osman NF, McVeigh ER, Prince JL. Imaging heart motion using harmonic phase MRI. IEEE Transactions on Medical Imaging 2000; 19: 186-202.
25. Heijman E, Strijkers GJ, Habets J, Janssen B, Nicolay K. Magnetic resonance imaging of regional cardiac function in the mouse. Magma 2004; 17: 170-178.
26. Streif JU, Herold V, Szimtenings M, Lanz TE, Nahrendorf M, Wiesmann F, Rommel E, Haase A. In vivo time-resolved quantitative motion mapping of the murine myocardiurn with phase contrast MRI. Magnetic Resonance in Medicine 2003; 49: 315-321.
27. Kolandaivelu A, Balaban RS, Wen H. Quantitative evaluation of regional strain in mice using SPAMM tagging and DENSE. Proc. Intl. Soc. Mag. Reson. Med. 2000; 8: 1610.
28. Gilson WD, Yang Z, French BA, Epstein FH. Complementary displacement-encoded MRI for contrast-enhanced infarct detection and quantification of myocardial function in mice. Magnetic Resonance in Medicine 2004; 51: 744-752.
29. Gilson WD, Yang Z, French BA, Epstein FH. Measurement of myocardial mechanics in mice before and after infarction using multislice displacement-encoded MRI with 3D motion encoding. American Journal of Physiology - Heart & Circulatory Physiology 2005; 288: H1491-H1497.
30. Moore CC, Lugo-Olivieri CH, McVeigh ER, Zerhouni EA. Three-dimensional systolic strain patterns in the normal human left ventricle: characterization with tagged MR imaging. Radiology 2000; 214: 453-466.
31. Benjelloun H, Cranney GB, Kirk KA, Blackwell GG, Lotan CS, Pohost GM. Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function. American Journal of Cardiology 1991; 67: 1413-1420.
32. Dulce MC, Mostbeck GH, Friese KK, Caputo GR, Higgins CB. Quantification of the left ventricular volumes and function with cine MR imaging: comparison of geometric models with three-dimensional data. Radiology 1993; 188: 371-376.
33. Power TP, Kramer CM, Shaffer AL, Theobald TM, Petruolo S, Reichek N, Rogers WJ. Breath-hold dobutamine magnetic resonance myocardial tagging: normal left ventricular response. American Journal of Cardiology 1997; 80: 1203-1207.
34. Vandsburger MH, French BA, Helm P, Roy RJ, Kramer CM, Epstein FH. CMR demonstrates markedly attenuated beta-adrenergic contractile response in nNOS knockout mice. Journal of Cardiovascular Magnetic Resonance 2006; 8(1): 65-66.
35. Young AA, Imai H, Chang CN, Axel L. Two-dimensional left ventricular deformation during systole using magnetic resonance imaging with spatial modulation of magnetization. Erratum appears in Circulation 1994; 90: 1584. Circulation 1994; 89: 740-752.
36. Streif JU, Nahrendorf M, Hiller KH, Waller C, Wiesmann F, Rommel E, Haase A, Bauer WR. In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging. Magnetic Resonance in Medicine 2005; 53: 584-592.
37. Belle V, Kahler E, Waller C, Rommel E, Voll S, Hiller KH, Bauer WR, Haase A. In vivo quantitative mapping of cardiac perfusion in rats using a noninvasive MR spin-labeling method. Journal of Magnetic Resonance Imaging 1998; 8: 1240-1245.
38. Waller C, Kabler E, Hiller KH, Hu K, Nahrendorf M, Voll S, Haase A, Ertl G, Bauer WR. Myocardial perfusion and intracapillary blood volume in rats at rest and with coronary dilatation. MR imaging in vivo with use of a spin-labeling technique. Radiology 2000; 215: 189-197.
39. Trabold F, Pons S, Hagege AA, Bloch-Faure M, Alhenc-Gelas F, Giudicelli JF, Richer-Giudicelli C, Meneton P. Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice. Hypertension 2002; 40: 90-95.
40. Decking UK, Pai VM, Bennett E, Taylor JL, Fingas CD, Zanger K, Wen H, Balaban RS. High-resolution imaging reveals a limit in spatial resolution of blood flow measurements by microspheres. American Journal of Physiology - Heart & Circulatory Physiology 2004; 287: H1132-H1140.
41. Chacko VP, Aresta F, Chacko SM, Weiss RG. MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates. American Journal of Physiology - Heart & Circulatory Physiology 2000; 279: H2218-H2224.
42. Naumova AV, Chacko VP, Ouwerkerk R, Stull L, Marban E, Weiss RG. Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts. American Journal of Physiology - Heart & Circulatory Physiology 2006; 290: H837-H843.
43. 31 P NMR spectroscopy. American Journal of Physiology - Heart & Circulatory Physiology 2003; 285: H1976-H1979.
44. Omerovic E, Basetti M, Bollano E, Bohlooly M, Torriell J, Isgaard J, Hjalmarson A, Soussi B, Waagstein F. In vivo metabolic imaging of cardiac bioenergetics in transgenic mice. Biochemical & Biophysical Research Communications 2000; 271: 222-228.
45. 1H-MRS in the mouse. Magnetic Resonance in Medicine 2004; 52: 1029-1035.
46. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New England Journal of Medicine 2000; 343: 1445-1453.
47. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
48. Yang Z, Berr SS, Gilson WD, Toufektsian MC, French BA. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation 2004; 109: 1161-1167.
49. French BA, Beyers RJ, Sureau FC, Yang Z, Gilson WD, Roy RJ, Epstein FH. Imaging infarct expansion in mice using a contrast-enhanced inversion recovery MRI sequence. Journal of Cardiovascular Magnetic Resonance 2005; 7: 172-173.
50. Thomas D, Dumont C, Pickup S, Misselwitz B, Zhou R, Horowitz J, Ferrari VA. T1-weighted cine FLASH is superior to IR imaging of post-infarction myocardial viability at 4.7T. Erratum appears in J Cardiovasc Magn Reson. 2006; 8: 683. Journal of Cardiovascular Magnetic Resonance 2006; 8: 345-352.
51. Hu TC, Pautler RG, MacGowan GA, Koretsky AP. Manganese-enhanced MRI of mouse heart during changes in inotropy. Magnetic Resonance in Medicine 2001; 46: 884-890.
52. Hu TC, Bao W, Lenhard SC, Schaeffer TR, Yue TL, Willette RN. Simultaneous assessment of left-ventricular infarction size, function and tissue viability in a murine model of myocardial infarction by cardiac manganese-enhanced magnetic resonance imaging (MEMRI). NMR in Biomedicine 2004; 17: 620-626.
53. Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenzweig A, Weissleder R, Josephson L. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magnetic Resonance in Medicine 2005; 54: 718-724.
54. ten Hove M, Lygate CA, Fischer A, Schneider JE, Sang AE, Hulbert K, Sebag-Montefiore L, Watkins H, Clarke K, Isbrandt D, Wallis J, Neubauer S. Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N-methyltransferase-knockout mice. Circulation 2005; 111: 2477-2485.
55. Schmidt A, Marescau B, Boehm EA, Renema WK, Peco R, Das A, Steinfeld R, Chan S, Wallis J, Davidoff M, Ullrich K, Waldschutz R, Heerschap A, De Deyn PP, Neubauer S, Isbrandt D. Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Human Molecular Genetics 2004; 13: 905-921.
56. Pyle WG, Sumandea MP, Solaro RJ, De Tombe PP. Troponin I serines 43/45 and regulation of cardiac myofilament function. American Journal of Physiology - Heart & Circulatory Physiology 2002; 283: H1215-H1224.
57. MacGowan GA, Evans C, Hu TC, Debrah D, Mullet S, Chen HH, McTiernan CF, Stewart AF, Koretsky AP, Shroff SG. Troponin I protein kinase C phosphorylation sites and ventricular function. Cardiovascular Research 2004; 63: 245-255.
58. Balligand JL. "La Donna e Mobile...": is cardiac neuronal nitric oxide synthase such a disconcerting enzyme? Circulation 2005; 112: 3668-3671.
59. Ashley EA, Sears CE, Bryant SM, Watkins HC, Casadei B. Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes. Circulation 2002; 105: 3011-3016.
60. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002; 416: 337-339.
61. Godecke A, Molojavyi A, Heger J, Flogel U, Ding Z, Jacoby C, Schrader J. Myoglobin protects the heart from inducible nitric-oxide synthase (iNOS)-mediated nitrosative stress. Journal of Biological Chemistry 2003; 278: 21761-21766.
62. Ross AJ, Yang Z, Berr SS, Gilson WD, Petersen WC, Oshinski JN, French BA. Serial MRI evaluation of cardiac structure and function in mice after reperfused myocardial infarction. Magnetic Resonance in Medicine 2002; 47: 1158-1168.
63. French BA, Yang Z, Berr SS, Kramer CM. Of mice and men... and broken hearts. Circulation 2001; 104: E110.
64. Yang Z, Bove CM, French BA, Epstein FH, Beff SS, DiMaria JM, Gibson JJ, Carey RM, Kramer CM. Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation 2002; 106: 106-111.
65. Bove CM, Gilson WD, Scott CD, Epstein FH, Yang Z, DiMaria JM, Berr SS, French BA, Bishop SP, Kramer CM. The angiotensin II type 2 receptor and improved adjacent region function post-MI. Journal of Cardiovascular Magnetic Resonance 2005; 7: 459-464.
66. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. American Heart Journal 1991; 122: 795-801.
67. Murakami Y, Zhang J, Eijgelshoven MH, Chen W, Carlyle WC, Zhang Y, Gong G, Bache RJ. Myocardial creatine kinase kinetics in hearts with postinfarction left ventricular remodeling. American Journal of Physiology 1999; 276: H892-H900.
68. Neubauer S, Horn M, Naumann A, Tian R, Hu K, Laser M, Friedrich J, Gaudron P, Schnackerz K, Ingwall JS. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. Journal of Clinical Investigation 1995; 95: 1092-1100.
69. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96: 2190-2196.
70. Nahrendorf M, Hu K, Frantz S, Jaffer FA, Tung CH, Hiller KH, Voll S, Nordbeck P, Sosnovik D, Gattenlohner S, Novikov M, Dickneite G, Reed GL, Jakob P, Rosenzweig A, Bauer WR, Weissleder R, Ertl G. Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation 2006; 113: 1196-1202.
71. Wildhirt SM, Schulze C, Conrad N, Kornberg A, Horstman D, Reichart B. Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischernia and reperfusion: implications for iNOS-mediated myocardial stunning. Thoracic & Cardiovascular Surgeon 1999; 47: 137-143.
72. Feng Q, Lu X, Jones DL, Shen J, Arnold JM. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 2001; 104: 700-704.
73. Gilson WD, Epstein FH, Yang Z, Laubach VE, Roy RJ, Berr SS, French BA. Cardiac MRI reveals reduced left ventricular remodeling after myocardial infarction in iNOS knock-out mice. Circulation 2003; 108: 700.
74. Gilson WD, Epstein FH, Roy RJ, Yang Z, French BA. Cine MRI and myocardial tagging reveal improved border zone function and reduced wall thinning in post-infarct iNOS knock-out mice. Circulation 2004; 110(17): 3176.
75. Epstein FH, Yang Z, Roy RJ, Xu Y, Beff SS, French BA. CMR demonstrates reduced post-infarct left ventricular remodeling in mice with iNOS inhibition. Journal of Cardiovascular Magnetic Resonance 2005; 7(1): 29-30.
76. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1998; 97: 1375-1381.
77. Engel D, Peshock R, Armstong RC, Sivasubramanian N, Mann DL. Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. American Journal of Physiology - Heart & Circulatory Physiology 2004; 287: H1303-H1311.
78. Flesch M, Hoper A, Dell'Italia L, Evans K, Bond R, Peshock R, Diwan A, Brinsa TA, Wei CC, Sivasubramanian N, Spinale FG, Mann DL. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2003; 108: 598-604.
79. De Souza AP, Cohen AW, Park DS, Woodman SE, Tang B, Gutstein DE, Factor SM, Tanowitz HB, Lisanti MP, Jelicks LA. MR imaging of caveolin gene-specific alterations in right ventricular wall thickness. Magnetic Resonance Imaging 2005; 23: 61-68.
80. Huang H, Chan J, Wittner M, Jelicks LA, Morris SA, Factor SM, Weiss LM, Braunstein VL, Bacchi CJ, Yarlett N, Chandra M, Shirani J, Tanowitz HB. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. Journal of Molecular & Cellular Cardiology 1999; 31: 75-88.
81. Jelicks LA, Chandra M, Shtutin V, Petkova SB, Tang B, Christ GJ, Factor SM, Wittner M, Huang H, Douglas SA, Weiss LM, Orleans-Juste PD, Shirani J, Tanowitz HB. Phosphoramidon treatment improves the consequences of chagasic heart disease in mice. Clinical Science 2002; 103(Suppl. 48): 267S-271S.
82. De Souza AP, Tanowitz HB, Chandra M, Shtutin V, Weiss LM, Morris SA, Factor SM, Huang H, Wittner M, Shirani J, Jelicks LA. Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitology Research 2004; 92: 496-501.
83. Lewis W, Miller YK, Haase CP, Ludaway T, McNaught J, Russ R, Steltzer J, Folpe A, Long R, Oshinski J. HIV viral protein R causes atrial cardiomyocyte mitosis, mesenchymal tumor, dysrhythmia, and heart failure. Laboratory Investigation 2005; 85: 182-192.
84. Nahrendorf M, Spindler M, Hu K, Bauer L, Ritter O, Nordbeck P, Quaschning T, Hiller KH, Wallis J, Ertl G, Bauer WR, Neubauer S. Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction. Cardiovascular Research 2005; 65: 419-427.
85. Shohet RV, Kisanuki YY, Zhao XS, Siddiquee Z, Franco F, Yanagisawa M. Mice with cardiornyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 2088-2093.
86. Wilding JR, Schneider JE, Sang AE, Davies KE, Neubauer S, Clarke K. Dystrophin- and MLP-deficient mouse hearts: marked differences in morphology and function, but similar accumulation of cytoskeletal proteins. FASEB Journal 2005; 19: 79-81.
87. Williams SP, Gerber HP, Giordano FJ, Peale FV Jr, Bernstein LJ, Bunting S, Chien KR, Ferrara N, van Bruggen N, Dobutamine stress cine-MRI of cardiac function in the hearts of adult cardiomyocyte-specific VEGF knockout mice. Journal of Magnetic Resonance Imaging 2001; 14: 374-382.
88. Weiss RG, Chatham JC, Georgakopolous D, Charron MJ, Wallimann T, Kay L, Walzel B, Wang Y, Kass DA, Gerstenblith G, Chacko VP. An increase in the myocardial PCr/ATP ratio in GLUT4 null mice. FASEB Journal 2002; 16: 613-615.
89. Martin M, Meyer-Kirchrath J, Kaber G, Jacoby C, Flogel U, Schrader J, Ruther U, Schror K, Hohlfeld T. Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury. Circulation 2005; 112: 400-406.
90. Syed F, Diwan A, Hahn HS. Murine echocardiography: a practical approach for phenotyping genetically manipulated and surgically modeled mice. Journal of the American Society of Echocardiography 2005; 18: 982-990.
91. Collins KA, Korcarz CE, Lang RM. Use of echocardiography for the phenotypic assessment of genetically altered mice. Physiological Genomics 2003; 13: 227-239.
92. Feintuch A, Ruengsakulrach P, Lin A, Zhang J, Zhou Y, Bishop J, Davidson L, Courtman D, Foster FS, Steinman D, Henkelman RM, Ethier CR. Hemodynamics in the mouse aortic arch as assessed by MRI, ultrasound and numerical modeling. Am J Physiol Heart Circ Physiol 2006; Epub ahead of print.
93. Schelbert HR, Inubushi M, Ross RS, Schelbert HR, Inubushi M, Ross RS. PET imaging in small animals. Journal of Nuclear Cardiology 2003; 10: 513-520.
94. Constantinesco A, Choquet P, Monassier L, Israel-Jost V, Mertz L. Assessment of left ventricular perfusion, volumes, and motion in mice using pinhole gated SPECT. Journal of Nuclear Medicine 2005; 46: 1005-1011.
95. Greschus S, Kiessling F, Lichy MP, Moll J, Mueller MM, Savai R, Rose F, Ruppert C, Gunther A, Luecke M, Fusenig NE, Semmler W, Traupe H. Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging. Neoplasia (New York) 2005; 7: 730-740.
96. Efimov IR, Nikolski VP, Salama G. Optical imaging of the heart. Circulation Research 2004; 95: 21-33.